These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19171155)

  • 21. Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.
    Simonelli C; Zanussi S; Cinelli R; Dal Maso L; Di Gennaro G; D'Andrea M; Nasti G; Spina M; Vaccher E; De Paoli P; Tirelli U
    Clin Infect Dis; 2003 Sep; 37(6):820-7. PubMed ID: 12955644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.
    Podsadecki TJ; Vrijens BC; Tousset EP; Rode RA; Hanna GJ
    J Infect Dis; 2007 Dec; 196(12):1773-8. PubMed ID: 18190257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 viral load blips are of limited clinical significance.
    Lee PK; Kieffer TL; Siliciano RF; Nettles RE
    J Antimicrob Chemother; 2006 May; 57(5):803-5. PubMed ID: 16533823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of anti-retroviral resistance of HIV-1 infected individuals on therapy: is it inevitable?
    Kolber MA; Campo RE; Dickinson GM
    IUBMB Life; 2004 Jun; 56(6):301-7. PubMed ID: 15370878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant link between sCD30 changes and HIV viremia in patients treated with HAART.
    Biswas P; Cozzi-Lepri A; Delfanti F; Galli A; Colangeli V; Moioli MC; Scarchilli A; Abrescia N; Vigevani G; D'Arminio-Monforte A; Novati R; Lazzarin A
    J Med Virol; 2006 Dec; 78(12):1513-9. PubMed ID: 17063513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma levels of lipopolysaccharide and high mobility group box-1 protein are associated with high viral load in HIV-1 infection: reduction by 2-year antiretroviral therapy.
    Trøseid M; Nowak P; Nyström J; Lindkvist A; Abdurahman S; Sönnerborg A
    AIDS; 2010 Jul; 24(11):1733-7. PubMed ID: 20502315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of HIV viral load in blood and semen of patients under HAART: impact of therapy in assisted reproduction procedures.
    La Sala GB; Pilotti E; Nicoli A; Pinelli S; Villani MT; Ronzi P; Zendri E; Re MC; Magnani G; Casoli C
    AIDS; 2007 Jan; 21(3):377-9. PubMed ID: 17255749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
    Zhang L; Ramratnam B; Tenner-Racz K; He Y; Vesanen M; Lewin S; Talal A; Racz P; Perelson AS; Korber BT; Markowitz M; Ho DD
    N Engl J Med; 1999 May; 340(21):1605-13. PubMed ID: 10341272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
    Marcello A; Giacca M
    Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
    [No Abstract]   [Full Text] [Related]  

  • 31. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A; Cox AE; Shamji MH; John L; Nelson M; Henderson DC; Gotch FM; Gazzard BG; Kelleher P
    Antivir Ther; 2007; 12(6):971-5. PubMed ID: 17926652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognosis of highly active antiretroviral therapy (HAART) treated HIV infected patients in Serbia, related to the time of treatment initiation.
    Jevtović Dj; Salemović D; Ranin J; Dulović O; Ilić D; Brmbolić B
    J Clin Virol; 2010 Feb; 47(2):131-5. PubMed ID: 20006540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.
    Deeks SG; Wrin T; Liegler T; Hoh R; Hayden M; Barbour JD; Hellmann NS; Petropoulos CJ; McCune JM; Hellerstein MK; Grant RM
    N Engl J Med; 2001 Feb; 344(7):472-80. PubMed ID: 11172188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful simplification of HAART in patients with acute primary HIV infection.
    Sinicco A; Bonora S; Arnaudo I; Zeme DA; Audagnotto S; Raiteri R; Di Perri G
    J Biol Regul Homeost Agents; 2002; 16(1):69-72. PubMed ID: 12003178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
    Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
    J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling HIV persistence, the latent reservoir, and viral blips.
    Rong L; Perelson AS
    J Theor Biol; 2009 Sep; 260(2):308-31. PubMed ID: 19539630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viral blip dynamics during highly active antiretroviral therapy.
    Di Mascio M; Markowitz M; Louie M; Hogan C; Hurley A; Chung C; Ho DD; Perelson AS
    J Virol; 2003 Nov; 77(22):12165-72. PubMed ID: 14581553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers of HIV replication.
    Siliciano JD; Siliciano RF
    Curr Opin HIV AIDS; 2010 Nov; 5(6):491-7. PubMed ID: 20978392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient viremia, plasma viral load, and reservoir replenishment in HIV-infected patients on antiretroviral therapy.
    Jones LE; Perelson AS
    J Acquir Immune Defic Syndr; 2007 Aug; 45(5):483-93. PubMed ID: 17496565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy.
    Wang S; Rong L
    J Theor Biol; 2014 Nov; 360():137-148. PubMed ID: 25016044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.